NewAmsterdam Pharma Co NV (FRA:KH6) Accounts Payable & Accrued Expense : €22.87 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is NewAmsterdam Pharma Co NV Accounts Payable & Accrued Expense?

NewAmsterdam Pharma Co NV's quarterly accounts payable & accrued expense increased from Dec. 2022 (€15.08 Mil) to Jun. 2023 (€20.92 Mil) and increased from Jun. 2023 (€20.92 Mil) to Dec. 2023 (€22.87 Mil).

NewAmsterdam Pharma Co NV's annual accounts payable & accrued expense increased from Dec. 2021 (€9.39 Mil) to Dec. 2022 (€15.08 Mil) and increased from Dec. 2022 (€15.08 Mil) to Dec. 2023 (€22.87 Mil).

NewAmsterdam Pharma Co NV Accounts Payable & Accrued Expense Historical Data

The historical data trend for NewAmsterdam Pharma Co NV's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NewAmsterdam Pharma Co NV Accounts Payable & Accrued Expense Chart

NewAmsterdam Pharma Co NV Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

1.17

9.39

15.08

22.87

NewAmsterdam Pharma Co NV Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial			9.39	11.64	15.08	20.92	22.87

NewAmsterdam Pharma Co NV Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

NewAmsterdam Pharma Co NV (FRA:KH6) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NewAmsterdam Pharma Co NV (FRA:KH6) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

NAMS:USA KH6:Germany

Address

Gooimeer 2-35, Naarden, NH, NLD, 1411 DC

Website

https://www.newamsterdampharma.com

NewAmsterdam Pharma Co NV is a clinical-stage company focused on the research and development of transformative therapies for metabolic diseases and Alzheimer's disease.

NewAmsterdam Pharma Co NV (FRA:KH6) Headlines

No Headlines